SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaera Corp
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jstrohs who wrote (82)5/25/2006 8:36:32 AM
From: DewDiligence_on_SI  Read Replies (1) of 96
 
That’s my point exactly: they are a placement agent, not a research firm with bona fide analysts.

The DJ report on GENR is laughable in its litany of misstatements. Perhaps the funniest one is that the 212 study “is positioned to show superiority or non-inferiority” to Lucentis. Hard to do when Lucentis is not even being tested in that study.

GENR is up a creek because they can’t get their phase-3 trial enrolled. A bullish report from Dawson Whoever isn’t going to help—except possibly at raising money in the next PIPE.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News